Atara Biotherapeutics
BioTech/Drugs - Thousand Oaks, California, US
Atara Biotherapeutics Employees
Matt Fazio
Director of Marketing, Rare Lymphomas', T-Cell therapies, Hematology, SOT
Atara Biotherapeutics Senior Management
Hyonelle Youngson
Vice President, Cultural Transformation and Chief of Staff to CEO at Atara Biotherapeutics
Atara Biotherapeutics Details
Atara Biotherapeutics Inc., is a leading allogeneic T-cell immunotherapy company pioneering the development of transformative off-the-shelf therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. With our lead program receiving marketing authorization in Europe, Atara is the most advanced allogeneic T-cell immunotherapy company and intends to rapidly deliver off-the-shelf treatments to patients with high unmet medical need. Our platform leverages the unique biology of EBV T cells and has the capability to treat a wide range of EBV-associated diseases, or other serious diseases through incorporation of engineered CARs (chimeric antigen receptors) or TCRs (T-cell receptors). Atara is applying this one platform, which does not require TCR or HLA gene editing, to create a robust pipeline including: tab-cel for Epstein-Barr virus positive post-transplant lymphoproliferative disease (EBV+ PTLD) and other EBV-driven diseases; ATA188, a T-cell immunotherapy targeting EBV antigens as a potential treatment for multiple sclerosis; and multiple next-generation chimeric antigen receptor T-cell (CAR-T) immunotherapies for both solid tumors and hematologic malignancies.
Atara Biotherapeutics Technologies
Email Providers
Outlook
Customer Relationship Management
Salesforce
Domain Name Services
Cloudflare DNS
Email Delivery
Rackspace MailGun
Other
Microsoft Office 365